Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Other Current Assets
Formosa Laboratories Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Other Current Assets
NT$194.6m
|
CAGR 3-Years
33%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Other Current Assets
NT$216.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
5%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Other Current Assets
NT$114.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Other Current Assets
NT$57.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
25%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Other Current Assets
NT$531.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
10%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Other Current Assets
NT$129.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Other Current Assets?
Other Current Assets
194.6m
TWD
Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Other Current Assets amounts to 194.6m TWD.
What is Formosa Laboratories Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
12%
Over the last year, the Other Current Assets growth was 75%. The average annual Other Current Assets growth rates for Formosa Laboratories Inc have been 33% over the past three years , 11% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet